| Relation | Metric | Value | YoY |
|---|
Where did the money come from, and where was it spent?
Revenue and operating profit grew together, indicating healthy core operations.
The largest revenue segment accounts for 84.96% of revenue, indicating concentration.
- Revenue
- USD 6.97B YoY +5.55%
- Largest revenue segment share (U. S. Dialysis And Related Lab Services)
- 84.96% YoY −1.48pp
- Selling, general and administrative
- USD 845.37M Share 12.13% · YoY +7.43%
- Interest expense
- USD 295.39M Share 4.24% · YoY +5.08%
View calculation evidence
YoY periods: H1 2026 compared with H1 2025
Source metrics
- Largest revenue segment share (U. S. Dialysis And Related Lab Services)U. S. Dialysis And Related Lab Services · segment_value / revenue * 100
- RevenueTotal revenues · Revenues
- Interest expenseInterest and debt expense · InterestAndDebtExpense
- Selling, general and administrativesum(SellingAndMarketingExpense, GeneralAndAdministrativeExpense)